Level C· Early human research exploring benefitsProspective StudyEurope PMCOpen access

Effectiveness of Exosome Treatment in Androgenetic Alopecia: Outcomes of a Prospective Study

Ersan M., Ozer E., Akin O., Tasli PN., Sahin F.

Prospective Study with a reported sample of 30 on Hair Loss, Hair Regeneration, published in Aesthetic Plast Surg (2024) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Aesthetic Plast Surg (2024)
Reported sample size
30
Source database
Europe PMC
PMID
39174804
PMCID
PMC11588828
DOI
10.1007/s00266-024-04332-3
Citations
19

Abstract (original English)

Objective Harnessing the regenerative capabilities of stem cell-derived exosomes holds great promise for developing novel hair growth therapies, offering hope for individuals experiencing hair loss or alopecia. This aimed to elucidate the effect of "foreskin-derived mesenchymal stromal cells derived exosome" injection into the scalp on hair density in patients with androgenetic alopecia and the contribution of this treatment on patient satisfaction. Method This prospective study included 30 male patients, aged between 22 and 65, with hair type III-VI according to the Norwood-Hamilton scale. Characterization of the stem cell exosomes was performed with the nanoparticle tracking analysis (NTA), hair densities were calculated via digital imaging analysis, and patient satisfaction was questioned with a modified survey. Results NTA results showed a characteristic distribution of peaks for exosomes 139.7 ± 2.3 nm in diameter. A statistically significant increase in hair density was observed in the 4th and 12th weeks after treatment (p Conclusion Foreskin-derived mesenchymal stromal cells derived exosome injection increased hair density, with sustained patient satisfaction throughout the study. The exosome application resulted in no side effects. Level of evidence iv This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansAlopeciaTreatment OutcomeProspective StudiesAdultAgedMiddle AgedPatient SatisfactionMaleExosomes

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research